TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
24 hedge funds and large institutions have $903K invested in TRACON Pharmaceuticals, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$72.2K | |
| 2 | +$72K | |
| 3 | +$33.5K | |
| 4 |
GS
GTS Securities
New York
|
+$2.76K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$140 |
Top Sellers
| 1 | -$848K | |
| 2 | -$62.5K | |
| 3 | -$6.33K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.82K |
| 5 |
BlackRock
New York
|
-$1.15K |